Initial Statement of Beneficial Ownership (3)
August 21 2017 - 3:19PM
Edgar (US Regulatory)
FORM 3
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0104
Estimated average burden
hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
Monarch Alternative Capital LP
|
2. Date of Event Requiring Statement (MM/DD/YYYY)
8/9/2017
|
3. Issuer Name
and
Ticker or Trading Symbol
Vanguard Natural Resources, Inc. [N/A]
|
(Last)
(First)
(Middle)
535 MADISON AVENUE,
|
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)
_____ Director
_____ 10% Owner
_____ Officer (give title below)
___
X
___ Other (specify below)
/ See Remarks
|
(Street)
NEW YORK, NY 10022
(City)
(State)
(Zip)
|
5. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
___ Form filed by One Reporting Person
_
X
_ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Beneficially Owned
|
1.Title of Security
(Instr. 4)
|
2. Amount of Securities Beneficially Owned
(Instr. 4)
|
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
|
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
|
Common Stock
|
90963
|
I
|
See footnotes
(1)
(2)
|
Common Stock
|
442034
|
I
|
See footnotes
(1)
(3)
|
Common Stock
|
511364
|
I
|
See footnotes
(1)
(4)
|
Common Stock
|
995841
|
I
|
See footnotes
(1)
(5)
|
Common Stock
|
2101
|
I
|
See footnotes
(1)
(6)
|
Table II - Derivative Securities Beneficially Owned (
e.g.
, puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security
(Instr. 4)
|
2. Date Exercisable and Expiration Date
(MM/DD/YYYY)
|
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
|
4. Conversion or Exercise Price of Derivative Security
|
5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
|
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
|
Date Exercisable
|
Expiration Date
|
Title
|
Amount or Number of Shares
|
Explanation of Responses:
|
(1)
|
This Form 3 is being filed on behalf of Monarch Alternative Capital LP, a Delaware limited partnership ("MAC"), MDRA GP LP, a Delaware limited partnership ("MDRA GP") and Monarch GP LLC, a Delaware limited liability company ("Monarch GP") (collectively, the "Reporting Persons"). MAC serves as the investment advisor to the Funds (as defined below), MDRA GP is the general partner of MAC, and Monarch GP is the general partner of MDRA GP. Each of MAC, MDRA GP and Monarch GP may be deemed to indirectly beneficially own Common Stock held directly by the Funds and disclaim beneficial ownership of all such Common Stock except to the extent of any indirect pecuniary interest therein.
|
(2)
|
Common Stock held directly by Monarch Alternative Solutions Master Fund Ltd, a Cayman Islands exempted company ("MASMF").
|
(3)
|
Common Stock held directly by Monarch Capital Master Partners III LP, a Cayman Islands limited partnership ("MCMP III").
|
(4)
|
Common Stock held directly by MCP Holdings Master LP - Series III-A, a Cayman Islands limited partnership ("MCP HM").
|
(5)
|
Common Stock held directly by Monarch Debt Recovery Master Fund Ltd, a Cayman Islands exempted company ("MDRF").
|
(6)
|
Common Stock held directly by P Monarch Recovery Ltd., a British Virgin Islands corporation ("P Monarch," and together with MASMF, MCMP III, MCP HM and MDRF, the "Funds").
|
Remarks:
Exhibit List:
Exhibit 99.1 - Joint Filer Information and Signatures
Solely for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), MAC (and MDRA GP and Monarch GP by virtue of their control of MAC) may be deemed to be directors-by-deputization by virtue of the Funds having a representative on the board of directors of Vanguard Natural Resources, Inc. (the "Board"). Joseph Citarrella, a principal of MAC, is a member of the Board. For purposes of the exemption under Rule 16b-3 promulgated under the Exchange Act, the Board approved the acquisition of any direct or indirect pecuniary interest of the shares of Common Stock reported herein by MAC.
|
Reporting Owners
|
Reporting Owner Name / Address
|
Relationships
|
Director
|
10% Owner
|
Officer
|
Other
|
Monarch Alternative Capital LP
535 MADISON AVENUE
NEW YORK, NY 10022
|
|
|
|
See Remarks
|
MDRA GP LP
C/O MONARCH ALTERNATIVE CAPITAL LP
535 MADISON AVENUE
NEW YORK, NY 10022
|
|
|
|
See Remarks
|
Monarch GP LLC
C/O MONARCH ALTERNATIVE CAPITAL LP
535 MADISON AVENUE
NEW YORK, NY 10022
|
|
X
|
|
See Remarks
|
Signatures
|
MONARCH ALTERNATIVE CAPITAL LP, By: /s/ Michael Weinstock, Chief Executive Officer
|
|
8/21/2017
|
**
Signature of Reporting Person
|
Date
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
|
*
|
If the form is filed by more than one reporting person,
see
Instruction 5(b)(v).
|
**
|
Intentional misstatements or omissions of facts constitute Federal Criminal Violations.
See
18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
|
Note:
|
File three copies of this Form, one of which must be manually signed. If space is insufficient,
see
Instruction 6 for procedure.
|
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
|